GSK Plc (G1SK34)
BOV
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 7.38B | 6.95B | 7.18B | 8.15B | 8.05B | 7.36B | 7.88B | 8.01B |
Operating Income | 3.01B | 2.08B | 2.14B | 1.95B | 572M | 1.49B | 1.65B | 188M |
Pre Tax Income | 1.63B | 1.91B | 1.99B | 1.79B | 379M | 1.36B | 1.5B | 64M |
Net Income | 1.71B | 1.49B | 1.62B | 1.46B | 350M | 1.05B | 1.17B | -58M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 3.23B | 2.08B | 2.14B | 1.95B | 572M | 1.49B | 1.65B | 188M |
EBITDA | 3.35B | 2.72B | 2.59B | 2.53B | 1.75B | 2.04B | 2.28B | 1.14B |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 27.89B | 30.19B | 30.82B | 33.75B | 34.1B | 34.11B | 34.91B | 30.33B |
Operating Income | 2.17B | 4.2B | 5.33B | 6.24B | 5.08B | 6.67B | 8.43B | 7.35B |
Pre Tax Income | 1.94B | 3.53B | 4.8B | 6.22B | 6.97B | 5.44B | 6.48B | 6.06B |
Net Income | 912M | 1.53B | 3.62B | 4.65B | 5.75B | 4.39B | 14.96B | 4.93B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.17 | 0.285 | 0.674 | 0.863 | 1.068 | 0.814 | 3.469 | 1.143 |
EBIT | 2.45B | 4.39B | 5.59B | 6.78B | 7.86B | 7.22B | 8.64B | 7.66B |
EBITDA | 4.15B | 7.13B | 7.52B | 9.37B | 8.15B | 9.32B | 11.05B | 10.11B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.